JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 1, 2007; DOI: 10.1124/jpet.107.122630


0022-3565/07/3232-415-421$20.00
JPET 323:415-421, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.122630v1
323/2/415    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Linder, A. E.
Right arrow Articles by Watts, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Linder, A. E.
Right arrow Articles by Watts, S. W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

PERSPECTIVES IN PHARMACOLOGY

Serotonin (5-HT) in Veins: Not All in Vain

A. Elizabeth Linder, Wei Ni, Jessica L. Diaz, Theodora Szasz, Robert Burnett, and Stephanie W. Watts

Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan

The circulatory system consists of veins and arteries. Compared with arteries, veins have been neglected in cardiovascular research. Although veins are significantly less muscular than similarly sized arteries, the contribution of veins to cardiovascular homeostasis cannot be left un-noted because veins accommodate 70% of the circulating blood. Circulating blood platelets contain the majority of systemic 5-HT (5-hydroxytryptamine; serotonin). Similar to venous function, the physiological role of 5-HT in the cardiovascular system is not well understood. Here, we present not only a review on 5-HT and veins but ways in which these two topics might intersect in a physiologically relevant manner. Here we show the novel findings that veins exhibit higher amounts of intracellular 5-HT than arteries. Moreover, we also show evidence that, similar to arteries, veins have the ability to uptake 5-HT. In this review, we introduce the venous system as a reservoir for 5-HT in the periphery, suggesting that veins, in addition to arteries, may represent an important target for drugs that interfere with the serotonergic system. In addition, the serotonergic system from synthesis to metabolism, 5-HT receptor activation and venous diseases will also be discussed.


Received March 12, 2007; accepted July 31, 2007.

Address correspondence to. A. Elizabeth Linder, Department of Pharmacology and Toxicology, Michigan State University, B445 Life Sciences Building, East Lansing, MI 48824. E-mail: linderau{at}msu.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
A. E. Linder, W. Ni, T. Szasz, R. Burnett, J. Diaz, T. J. Geddes, D. M. Kuhn, and S. W. Watts
A Serotonergic System in Veins: Serotonin Transporter-Independent Uptake
J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 714 - 722.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.